TITLE:
African-American Heart Failure Trial

CONDITION:
Congestive Heart Failure

INTERVENTION:
BiDil

SUMMARY:

      A placebo-controlled trial of BiDil added to standard therapy in African-American patients
      with heart failure.
    

DETAILED DESCRIPTION:

      The overall objective is confirmation of BiDils Safety and Efficacy in African-American
      (AFA) Patients with Moderate to Severe Symptomatic Heart Failure.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  African American male or female 18 years or older.

          -  NYHA Class 3 & 4.

          -  Have either a resting LVEF less than or equal to 35% (by any method) or a resting
             LVIDD greater than 2.9 cm/m2 BSA (or greater than 6.5 cm) with LVEF less than 45% (by
             echocardiogram).
      
